Clinically important differences in the intensity of chronic refractory breathlessness

Journal of Pain and Symptom Management

Volumn 46, Issue 6, 2013, Pages 957-963

  Johnson, Miriam J ^a   Bland, J Martin ^b   Oxberry, Stephen G ^c   Abernethy, Amy P ^d,e   Currow, David C ^e  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c Palliative Medicine Kirkwood Hospice   (United Kingdom)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

breathlessness; dyspnea; Minimal clinically important difference; opioid

Indexed keywords

MORPHINE; OXYCODONE;

AGED; ARTICLE; CHRONIC DISEASE; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SCORING SYSTEM;

BREATHLESSNESS; DYSPNEA; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; OPIOID;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DYSPNEA; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84888645683     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2013.01.011     Document Type: Article

References (30)

1. M.J. Johnson, S.G. Oxberry, J.G. Cleland, and A.L. Clark Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review Eur J Heart Fail 12 2010 137 147
2. P.S. Pang, J.G. Cleland, and J.R. Teerlink A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur Heart J 29 2008 816 824
3. C. Bausewein, M. Farquhar, S. Booth, M. Gysels, and I.J. Higginson Measurement of breathlessness in advanced disease: a systematic review Respir Med 101 2007 399 410
4. C. Bausewein, S. Booth, and I.J. Higginson Measurement of dyspnoea in the clinical rather than the research setting Curr Opin Support Palliat Care 2 2008 95 99
5. S. Dorman, A. Byrne, and A. Edwards Which measurement scales should we use to measure breathlessness in palliative care? A systematic review Palliat Med 21 2007 177 191
6. S. Dorman, C. Jolley, and A. Abernethy Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup Palliat Med 23 2009 213 227
7. S.G. Oxberry, J.M. Bland, A.L. Clark, J.G. Cleland, and M.J. Johnson Minimally clinically important difference (MCID) in chronic breathlessness: every little helps Am Heart J 164 2012 229 235
8. H.C. de Vet, C.B. Terwee, and R.W. Ostelo Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change Health Qual Life Outcomes 4 2006 54
9. G.H. Guyatt, D. Osoba, A.W. Wu, K.W. Wyrwich, and G.R. Norman Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 2002 371 383
10. R. Jaeschke, J. Singer, and G.H. Guyatt Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415
11. M.J. Johnson, T.A. McDonagh, A. Harkness, S.E. McKay, and H.J. Dargie Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study Eur J Heart Fail 4 2002 753 756
12. S.G. Oxberry, D.J. Torgerson, and J.M. Bland Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial Eur J Heart Fail 13 2011 1006 1012
13. A.P. Abernethy, D.C. Currow, and P. Frith Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 528
14. D.C. Currow, C. McDonald, and S. Oaten Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study J Pain Symptom Manage 42 2011 388 399
15. J. Powers, and S.J. Bennett Measurement of dyspnea in patients treated with mechanical ventilation Am J Crit Care 8 1999 254 261
16. M.J. Hjermstad, P.M. Fayers, and D.F. Haugen Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review J Pain Symptom Manage 41 2011 1073 1093
17. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed. 1988 Lawrence Erlbaum Hillsdale, NJ
18. A.L. Ries Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale COPD 2 2005 105 110
19. J.P. de Torres, V. Pinto-Plata, and E. Ingenito Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD Chest 121 2002 1092 1098
20. K. Foglio, L. Bianchi, and G. Bruletti Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction Eur Respir J 13 1999 125 132
21. J. Reardon, E. Awad, and E. Normandin The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea Chest 105 1994 1046 1052
22. V. Alvisi, T. Mirkovic, P. Nesme, C. Guerin, and J. Milic-Emili Acute effects of hyperoxia on dyspnea in hypoxemia patients with chronic airway obstruction at rest Chest 123 2003 1038 1046
23. F.J. Martinez, M.M. de Oca, and R.I. Whyte Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function Am J Respir Crit care Med 155 1997 1984 1990
24. D.J. Karras, M.E. Sammon, and C.A. Terregino Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327 334
25. D.S. Ander, I.P. Aisiku, J.J. Ratcliff, K.H. Todd, and K. Gotsch Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 10 2004 188 191
26. M. Gysels, and I.J. Higginson Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness J Pain Symptom Manage 36 2008 451 460
27. M. Gysels, and I.J. Higginson The experience of breathlessness: the social course of chronic obstructive pulmonary disease J Pain Symptom Manage 39 2010 555 563
28. D.C. Currow, J. Smith, and P.M. Davidson Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study J Pain Symptom Manage 39 2010 680 690
29. H. Seow, L. Barbera, and R. Sutradhar Trajectory of performance status and symptom scores for patients with cancer during the last six months of life J Clin Oncol 29 2011 1151 1158
30. Improving research methodology in breathlessness: a meeting convened by the MRC clinical trials unit and the Cicely Saunders Foundation Palliat Med 20 2006 219 220